Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iBio (IBIO) Revenue (2016 - 2025)

iBio (IBIO) has disclosed Revenue for 16 consecutive years, with $100000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Revenue changed N/A to $100000.0 in Q3 2025 year-over-year; TTM through Dec 2025 was $300000.0, a 20.0% decrease, with the full-year FY2025 number at $400000.0, up 77.78% from a year prior.
  • Revenue was $100000.0 for Q3 2025 at iBio, down from $200000.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $1.8 million in Q1 2022 to a low of $50000.0 in Q3 2023.
  • A 5-year average of $429444.4 and a median of $200000.0 in 2024 define the central range for Revenue.
  • Biggest YoY gain for Revenue was 696.88% in 2021; the steepest drop was 79.51% in 2021.
  • iBio's Revenue stood at $84000.0 in 2021, then skyrocketed by 2042.86% to $1.8 million in 2022, then crashed by 97.22% to $50000.0 in 2023, then skyrocketed by 300.0% to $200000.0 in 2024, then plummeted by 50.0% to $100000.0 in 2025.
  • Per Business Quant, the three most recent readings for IBIO's Revenue are $100000.0 (Q3 2025), $200000.0 (Q2 2025), and $200000.0 (Q4 2024).